Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a common drug stop polyps in teens with inherited colon cancer risk?

NCT ID NCT06308445

First seen May 11, 2026 · Last updated May 20, 2026 · Updated 3 times

Summary

This study tests whether the drug rapamycin is safe for teenagers aged 12 to 17 with familial adenomatous polyposis (FAP), a condition that causes many polyps in the colon and raises cancer risk. Researchers will give two low doses of rapamycin to 25 participants and watch for side effects. They will also check if the drug reduces the number or size of polyps.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FAMILIAL ADENOMATOUS POLYPOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • APHP Hôpital Robert Debré

    Paris, 75019, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU Bordeaux Hôpital Pellegrin

    Bordeaux, 33076, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • CHU Montpellier Hôpital Arnaud de Villeneuve

    Montpellier, 34295, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU Toulouse Hôpital des Enfants

    Toulouse, 31300, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.